133 related articles for article (PubMed ID: 20822954)
21. Correlation of serum CA125 with stage, grade and survival of patients with epithelial ovarian cancer at a single centre.
Osman N; O'Leary N; Mulcahy E; Barrett N; Wallis F; Hickey K; Gupta R
Ir Med J; 2008 Sep; 101(8):245-7. PubMed ID: 18990955
[TBL] [Abstract][Full Text] [Related]
22. [The sensitivity of the CA125 immunoradiometric assay for patients with epithelial ovarian cancer and its correlation with complex treatment].
Shi W; Zhang YJ; Jiang CY
Zhonghua Fu Chan Ke Za Zhi; 1994 Oct; 29(10):604-6, 637-8. PubMed ID: 7712875
[TBL] [Abstract][Full Text] [Related]
23. Improvement in risk stratification with the combination of the tumour marker antigen carbohydrate 125 and brain natriuretic peptide in patients with acute heart failure.
Núñez J; Sanchis J; Bodí V; Fonarow GC; Núñez E; Bertomeu-González V; Miñana G; Consuegra L; Bosch MJ; Carratalá A; Chorro FJ; Llàcer A
Eur Heart J; 2010 Jul; 31(14):1752-63. PubMed ID: 20501480
[TBL] [Abstract][Full Text] [Related]
24. Antigen carbohydrate 125 and creatinine on admission for prediction of renal function response following loop diuretic administration in acute heart failure.
Núñez J; Llàcer P; Núñez E; Ventura S; Bonanad C; Bodí V; Miñana G; Santas E; Mascarell B; Fonarow GC; Chorro FJ; Sanchis J
Int J Cardiol; 2014 Jul; 174(3):516-23. PubMed ID: 24801083
[TBL] [Abstract][Full Text] [Related]
25. New mechanism of elevated CA125 in heart failure: the mechanical stress and inflammatory stimuli initiate CA125 synthesis.
Huang F; Chen J; Liu Y; Zhang K; Wang J; Huang H
Med Hypotheses; 2012 Sep; 79(3):381-3. PubMed ID: 22743023
[TBL] [Abstract][Full Text] [Related]
26. Clinical value of CEA and CA125 regarding relapse and metastasis in resectable non-small cell lung cancer.
Gaspar MJ; Diez M; Rodriguez A; Ratia T; Martin Duce A; Galvan M; Granell J; Coca C
Anticancer Res; 2003; 23(4):3427-32. PubMed ID: 12926084
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of serum CA125 in nephrotic syndrome.
Peng T; Guo L; Xia Q; Yang X
Clin Lab; 2012; 58(1-2):113-5. PubMed ID: 22372353
[TBL] [Abstract][Full Text] [Related]
28. Serum levels of cancer antigen 125 and interleukin-15 in relation to the nutrition status of peritoneal dialysis patients.
Grzegorzewska AE; Mlot M; Leande M
Adv Perit Dial; 2004; 20():185-9. PubMed ID: 15384823
[TBL] [Abstract][Full Text] [Related]
29. Pre-operative prediction of serum CA125 level in women with ovarian masses.
Benjapibal M; Neungton C
J Med Assoc Thai; 2007 Oct; 90(10):1986-91. PubMed ID: 18041413
[TBL] [Abstract][Full Text] [Related]
30. Ovarian vein vs peripheral blood CA125 serum levels: a comparative study.
Podnos YD; Gamboa G; Kurosaki T; Buller R; Walker JL; Manetta A
Gynecol Oncol; 1997 Jul; 66(1):71-4. PubMed ID: 9234924
[TBL] [Abstract][Full Text] [Related]
31. CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients. From The Danish "MALOVA" Ovarian Cancer Study.
Høgdall EV; Christensen L; Kjaer SK; Blaakaer J; Kjaerbye-Thygesen A; Gayther S; Jacobs IJ; Høgdall CK
Gynecol Oncol; 2007 Mar; 104(3):508-15. PubMed ID: 17113137
[TBL] [Abstract][Full Text] [Related]
32. Personalizing CA125 levels for ovarian cancer screening.
Dorigo O; Berek JS
Cancer Prev Res (Phila); 2011 Sep; 4(9):1356-9. PubMed ID: 21893498
[TBL] [Abstract][Full Text] [Related]
33. Serial determinations of aminoterminal propeptide of type III procollagen (PIIINP) and prognosis in ovarian cancer; comparison to CA125.
Simojoki M; Santala M; Risteli J; Risteli L; Kauppila A
Anticancer Res; 2000; 20(6C):4655-60. PubMed ID: 11205196
[TBL] [Abstract][Full Text] [Related]
34. The prognostic value of pre-operative serum tetranectin, CA-125 and a combined index in women with primary ovarian cancer.
Høgdall CK; Nørgaard-Pedersen B; Mogensen O
Anticancer Res; 2002; 22(3):1765-8. PubMed ID: 12168866
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic laparoscopy, serum CA125, and peritoneal metastasis in gastric cancer.
Fujimura T; Kinami S; Ninomiya I; Kitagawa H; Fushida S; Nishimura G; Kayahara M; Shimizu K; Ohta T; Miwa K
Endoscopy; 2002 Jul; 34(7):569-74. PubMed ID: 12170412
[TBL] [Abstract][Full Text] [Related]
36. Estimation of CA 125 concentration in patients with congestive heart failure.
Skórzyńska H; Solski J; Gernand W; Matras P; Gniwek M; Sokół M
Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):261-4. PubMed ID: 16145993
[TBL] [Abstract][Full Text] [Related]
37. Esophageal cyst producing CA19-9 and CA125.
Goto T; Maeshima A; Oyamada Y; Kato R
Interact Cardiovasc Thorac Surg; 2010 Mar; 10(3):448-50. PubMed ID: 20008896
[TBL] [Abstract][Full Text] [Related]
38. [Tumor marker in ovarian cancer].
Komai K; Nishida T
Gan To Kagaku Ryoho; 2002 Mar; 29(3):481-6. PubMed ID: 11915744
[TBL] [Abstract][Full Text] [Related]
39. CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapy.
Juretzka MM; Barakat RR; Chi DS; Iasonos A; Dupont J; Abu-Rustum NR; Poynor EA; Aghajanian C; Spriggs D; Hensley ML; Sabbatini P
Gynecol Oncol; 2007 Jan; 104(1):176-80. PubMed ID: 16996584
[TBL] [Abstract][Full Text] [Related]
40. Preoperative serum tetranectin, CA125 and menopausal status used as single markers in screening and in a risk assessment index (RAI) in discriminating between benign and malignant ovarian tumors.
Begum FD; Høgdall E; Kjaer SK; Blaakaer J; Christensen IJ; Christensen L; Høgdall C
Gynecol Oncol; 2009 May; 113(2):221-7. PubMed ID: 19261323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
